Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard Witzenbichler

Showing results (1-10 of 222) with videos related to

Pageof 23
Sort By:
Journal of the American College of Cardiology|September 25, 2012
Dual antiplatelet therapy after drug-eluting stent implantation: is it time to slacken the reins?Bernhard Witzenbichler
Circulation|August 10, 2005
Images in cardiovascular medicine. Myocardial infarction caused by occlusion of Cabrol conduit graftBernhard Witzenbichler, Peter Schwimmbeck, Heinz-Peter Schultheiss
Circulation|December 22, 2004
Protective role of angiopoietin-1 in endotoxic shockBernhard Witzenbichler, Dirk Westermann, Sabine Knueppel, et al.
The American Journal of Cardiology|September 21, 2014
Postprocedural anticoagulation for specific therapeutic indications after revascularization for ST-segment elevation myocardial infarction (from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial)Mahesh V Madhavan, Philippe Généreux, Ajay J Kirtane, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 4, 2006
Intramuscular gene transfer of fibroblast growth factor-1 using improved pCOR plasmid design stimulates collateral formation in a rabbit ischemic hindlimb modelBernhard Witzenbichler, Abderrahim Mahfoudi, Fabienne Soubrier, et al.
European Heart Journal. Acute Cardiovascular Care|July 1, 2015
Is routine post-procedural anticoagulation warranted after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction? Insights from the HORIZONS-AMI trialMahesh V Madhavan, Philippe Généreux, Ajay J Kirtane, et al.
American Heart Journal|October 11, 2011
Incidence and predictors of heart failure following percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI trialDamian J Kelly, Tony Gershlick, Bernhard Witzenbichler, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|December 17, 2008
Prehospital versus periprocedural abciximab in ST-elevation myocardial infarction treated by percutaneous coronary interventionKlaus Pels, Joachim Schröder, Bernhard Witzenbichler, et al.
Coronary Artery Disease|January 25, 2017
Comparison of plaque morphology between peripheral and coronary artery disease (from the CLARITY and ADAPT-DES IVUS substudies)Da Yin, Mitsuaki Matsumura, John Rundback, et al.
The American Journal of Cardiology|August 14, 2014
Impact of pre-procedural cardiopulmonary instability in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial)Sorin J Brener, Bruce R Brodie, Alejandra Guerchicoff, et al.
Pageof 23

Showing results (1-10 of 222) with videos related to

Sort By:
Pageof 23
Journal of the American College of Cardiology|September 25, 2012
Dual antiplatelet therapy after drug-eluting stent implantation: is it time to slacken the reins?Bernhard Witzenbichler
Circulation|August 10, 2005
Images in cardiovascular medicine. Myocardial infarction caused by occlusion of Cabrol conduit graftBernhard Witzenbichler, Peter Schwimmbeck, Heinz-Peter Schultheiss
Circulation|December 22, 2004
Protective role of angiopoietin-1 in endotoxic shockBernhard Witzenbichler, Dirk Westermann, Sabine Knueppel, et al.
The American Journal of Cardiology|September 21, 2014
Postprocedural anticoagulation for specific therapeutic indications after revascularization for ST-segment elevation myocardial infarction (from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial)Mahesh V Madhavan, Philippe Généreux, Ajay J Kirtane, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 4, 2006
Intramuscular gene transfer of fibroblast growth factor-1 using improved pCOR plasmid design stimulates collateral formation in a rabbit ischemic hindlimb modelBernhard Witzenbichler, Abderrahim Mahfoudi, Fabienne Soubrier, et al.
European Heart Journal. Acute Cardiovascular Care|July 1, 2015
Is routine post-procedural anticoagulation warranted after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction? Insights from the HORIZONS-AMI trialMahesh V Madhavan, Philippe Généreux, Ajay J Kirtane, et al.
American Heart Journal|October 11, 2011
Incidence and predictors of heart failure following percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI trialDamian J Kelly, Tony Gershlick, Bernhard Witzenbichler, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|December 17, 2008
Prehospital versus periprocedural abciximab in ST-elevation myocardial infarction treated by percutaneous coronary interventionKlaus Pels, Joachim Schröder, Bernhard Witzenbichler, et al.
Coronary Artery Disease|January 25, 2017
Comparison of plaque morphology between peripheral and coronary artery disease (from the CLARITY and ADAPT-DES IVUS substudies)Da Yin, Mitsuaki Matsumura, John Rundback, et al.
The American Journal of Cardiology|August 14, 2014
Impact of pre-procedural cardiopulmonary instability in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial)Sorin J Brener, Bruce R Brodie, Alejandra Guerchicoff, et al.
Pageof 23